HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 78 filers reported holding HARVARD BIOSCIENCE INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $5,148,000 | +35.3% | 908,000 | -2.4% | 0.51% | +57.5% |
| Q3 2014 | $3,804,000 | -10.1% | 930,000 | 0.0% | 0.32% | 0.0% |
| Q2 2014 | $4,232,000 | -4.0% | 930,000 | 0.0% | 0.32% | -1.5% |
| Q1 2014 | $4,408,000 | +0.8% | 930,000 | 0.0% | 0.33% | +6.1% |
| Q4 2013 | $4,371,000 | -16.9% | 930,000 | -7.0% | 0.31% | +7.6% |
| Q3 2013 | $5,260,000 | +11.2% | 1,000,000 | 0.0% | 0.29% | +34.4% |
| Q2 2013 | $4,730,000 | – | 1,000,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,000,000 | $10,980,000 | 12.55% |
| 272 Capital LP | 3,062,963 | $16,815,667 | 6.18% |
| Meros Investment Management, LP | 813,014 | $4,463,447 | 2.21% |
| Harvey Partners, LLC | 2,524,000 | $13,856,760 | 1.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,862,649 | $15,715,943 | 0.96% |
| BARD ASSOCIATES INC | 286,922 | $1,575,202 | 0.61% |
| Acuitas Investments, LLC | 180,300 | $989,847 | 0.58% |
| Portolan Capital Management | 783,591 | $4,301,915 | 0.38% |
| Archon Capital Management LLC | 279,358 | $1,533,675 | 0.32% |
| HEARTLAND ADVISORS INC | 850,000 | $4,666,500 | 0.27% |